121 related articles for article (PubMed ID: 12746162)
1. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group.
Ek T; Mellander L; Andersson B; Abrahamsson J
Pediatr Blood Cancer; 2005 May; 44(5):461-8. PubMed ID: 15558707
[TBL] [Abstract][Full Text] [Related]
3. [T lymphocyte alpha/beta and gamma/delta in peripheral blood of children with acute lymphoblastic leukemia].
Mazur B; Wylezoł I; Sońta-Jakimczyk D
Wiad Lek; 2002; 55(5-6):282-7. PubMed ID: 12235694
[TBL] [Abstract][Full Text] [Related]
4. [The evaluation of peripheral blood lymphoid cells in children in remission a year after the cessation of treatment for acute lymphoblastic leukemia and non-Hodgkin's lymphoma type non-B].
Wylezoł I; Mazur B; Sońta-Jakimczyk D; Olejnik I
Wiad Lek; 1998; 51 Suppl 4():140-4. PubMed ID: 10731958
[TBL] [Abstract][Full Text] [Related]
5. Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy.
Mazur B; Mertas A; Sońta-Jakimczyk D; Szczepański T; Janik-Moszant A
Hematol Oncol; 2004 Mar; 22(1):27-34. PubMed ID: 15152368
[TBL] [Abstract][Full Text] [Related]
6. Immunologic monitoring of maintenance therapy for acute lymphoblastic leukaemia in children-preliminary report.
Luczynski W; Stasiak-Barmuta A; Krawczuk-Rybak M
Pediatr Blood Cancer; 2004 May; 42(5):416-20. PubMed ID: 15049012
[TBL] [Abstract][Full Text] [Related]
7. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children].
Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M
Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084
[TBL] [Abstract][Full Text] [Related]
8. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].
Kaftański R
Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275
[TBL] [Abstract][Full Text] [Related]
9. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia.
Lehrnbecher T; Schubert R; Behl M; Koenig M; Rose MA; Koehl U; Meisel R; Laws HJ
Br J Haematol; 2009 Dec; 147(5):700-5. PubMed ID: 19764991
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of the relation between immune dysfunction and treatment intensity in children with acute lymphoblastic leukemia.
Ek T; Josefson M; Abrahamsson J
Pediatr Blood Cancer; 2011 Jul; 56(7):1078-87. PubMed ID: 21344616
[TBL] [Abstract][Full Text] [Related]
11. [The function of the immune system after the treatment of pediatric malignant diseases].
Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
[TBL] [Abstract][Full Text] [Related]
12. Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
Mazur B; Szczepański T; Karpe J; Sońta-Jakimczyk D; Bubała H; Torbus M
Leuk Res; 2006 Jan; 30(1):33-6. PubMed ID: 16039713
[TBL] [Abstract][Full Text] [Related]
13. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
14. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
15. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
16. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
[TBL] [Abstract][Full Text] [Related]
18. [Th1/Th2 balance in acute lymphoblastic leukemia in children].
Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I; Matysiak M; Mitura-Lesiuk M; Kowalczyk J; Jeromin A
Przegl Lek; 2004; 61(9):919-23. PubMed ID: 15803899
[TBL] [Abstract][Full Text] [Related]
19. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children.
Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I
Arch Immunol Ther Exp (Warsz); 2005; 53(4):357-63. PubMed ID: 16088321
[TBL] [Abstract][Full Text] [Related]
20. [Herpes zoster-associated morbidity in children undergoing chemotherapy for acute lymphoblastic leukaemia].
Sørensen GV; Helgestad J; Rosthøj S
Ugeskr Laeger; 2009 Nov; 171(46):3350-4. PubMed ID: 19925740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
